People · Operator
Named in public records as an officer, director or promoter · active 2015–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| D2G Oncology, Inc. | — | Biotechnology | Series A | $8.7M | $316.3M | 2020 |
| UberSeq, Inc. | — | Biotechnology | Pre-Seed | $675K | $16.6M | 2015 |
Dmitri Petrov at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dmitri Petrov on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Amit Kumar | 1 | 8 |
| Jonathan MacQuitty | 1 | 7 |
| Kathy LaPorte | 1 | 2 |
| Monte Winslow | 1 | 1 |
| Sam Tolkoff | 1 | 1 |
| Alexi Andreev | 1 | 1 |
| Kathleen D. LaPorte | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.